Nuveen Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $741K | Hold |
154,750
| – | – | ﹤0.01% | 2832 |
|
2024
Q3 | $726K | Sell |
154,750
-372,073
| -71% | -$1.75M | ﹤0.01% | 2884 |
|
2024
Q2 | $2.98M | Buy |
526,823
+224,173
| +74% | +$1.27M | ﹤0.01% | 2190 |
|
2024
Q1 | $1.24M | Buy |
302,650
+147,900
| +96% | +$608K | ﹤0.01% | 2612 |
|
2023
Q4 | $653K | Buy |
154,750
+1,436
| +0.9% | +$6.06K | ﹤0.01% | 2919 |
|
2023
Q3 | $662K | Sell |
153,314
-246,689
| -62% | -$1.07M | ﹤0.01% | 2743 |
|
2023
Q2 | $2.64M | Sell |
400,003
-193,685
| -33% | -$1.28M | ﹤0.01% | 2221 |
|
2023
Q1 | $4.03M | Buy |
593,688
+21,073
| +4% | +$143K | ﹤0.01% | 2011 |
|
2022
Q4 | $4.23M | Sell |
572,615
-506,276
| -47% | -$3.74M | ﹤0.01% | 2004 |
|
2022
Q3 | $10.7M | Buy |
1,078,891
+91,106
| +9% | +$900K | ﹤0.01% | 1435 |
|
2022
Q2 | $10.8M | Buy |
987,785
+7,018
| +0.7% | +$76.5K | ﹤0.01% | 1455 |
|
2022
Q1 | $11.3M | Sell |
980,767
-15,601
| -2% | -$180K | ﹤0.01% | 1562 |
|
2021
Q4 | $15.6M | Buy |
996,368
+171,565
| +21% | +$2.69M | ﹤0.01% | 1386 |
|
2021
Q3 | $14.1M | Buy |
824,803
+588,107
| +248% | +$10.1M | ﹤0.01% | 1529 |
|
2021
Q2 | $5.09M | Sell |
236,696
-9,053
| -4% | -$195K | ﹤0.01% | 2238 |
|
2021
Q1 | $3.69M | Sell |
245,749
-6,389
| -3% | -$96K | ﹤0.01% | 2321 |
|
2020
Q4 | $3.31M | Buy |
252,138
+590
| +0.2% | +$7.75K | ﹤0.01% | 2263 |
|
2020
Q3 | $2.43M | Sell |
251,548
-22,896
| -8% | -$221K | ﹤0.01% | 2286 |
|
2020
Q2 | $3.14M | Sell |
274,444
-525,247
| -66% | -$6.01M | ﹤0.01% | 2133 |
|
2020
Q1 | $8.28M | Sell |
799,691
-220,168
| -22% | -$2.28M | ﹤0.01% | 1411 |
|
2019
Q4 | $16.7M | Sell |
1,019,859
-144,247
| -12% | -$2.37M | 0.01% | 1271 |
|
2019
Q3 | $15.5M | Buy |
1,164,106
+213,959
| +23% | +$2.84M | 0.01% | 1296 |
|
2019
Q2 | $13.4M | Buy |
+950,147
| New | +$13.4M | 0.01% | 1419 |
|